FOXD2-AS1 expression indicated poor DFS in urinary (Figure 8H), respiratory (Figure 8F), and head and neck tumors (Figure 8L), but FOXD2-AS1 expression was not related to DFS in hepatobiliary and pancreatic cancers (Figure 8D). This evidence concerns the gene FOXD2 and familial pancreatic carcinoma.